Entities / Company
Can-Fite BioPharma (Israel).
company in Petah Tikva, Israel
- Reports this week
- 0
- Active events
- 0
- Connections
- 20
What's happening
Gone quiet
No new reports in 90+ daysNo events began in the chosen period. Widen it, or reset.
Around Can-Fite BioPharma (Israel) this week
News at the entities that move Can-Fite BioPharma (Israel) most-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves Can-Fite BioPharma (Israel)
-
UWM Holdings Corp filed an 8-K with the Securities and Exchange Commission (Bangladesh) on May 13, 2026.
Moves Can-Fite BioPharma (Israel)
Connections
The 4 strongest of 20, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
Can-Fite BioPharma seeks and receives regulatory designations and approvals from the FDA for its pharmaceutical products.
-
Mash Operational
Can-Fite BioPharma is developing and evaluating Namodenoson as a treatment for the MASH indication.
-
HCC Transactional
HCC functions as the exclusive placement agent for Can-Fite BioPharma's drug Namodenoson.
-
Can-Fite BioPharma is subject to the regulatory oversight and filing requirements of the Securities and Exchange Commission of Bangladesh.